News
Why Zevra Therapeutics Stock Zoomed 21% Higher Today
Zevra Therapeutics (NASDAQ: ZVRA) was one of the healthier companies on the stock exchange on Tuesday. Investors eagerly piled into its shares following the commercial-stage biotech's latest
Finance of America (FOA) Earnings Transcript
Image source: The Motley Fool.
Tuesday, March 10, 2026 at 5 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
OpenAI Gave Amazing News to Amazon Shareholders
In today's video, I discuss recent updates affecting Amazon (NASDAQ: AMZN) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special offer link
Concrete Pumping (BBCP) Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, March 10, 2026 at 5 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Union Square Park Sells Mohawk Industries Stock
On Feb. 17, 2026, Union Square Park Capital Management, LLC disclosed in an SEC filing that it sold its entire 40,000-share position in Mohawk Industries (NYSE:MHK) in the fourth quarter.
According
Top 3 Consumer Staples Dividend Stocks for Reliable Income in 2026
Reliable income in consumer staples does not require buying the same 10 mega-cap names every financial news outlet recommends. Deeper in the market, a handful of overlooked companies are paying and
Why Oracle Stock Is Ripping Higher in After-Hours Trading
Dipping 1.4% during regular trading hours today, Oracle (NYSE: ORCL) stock is shooting higher during after-hours trading. With the tech company reporting third-quarter 2026 financial results that
Is Wingstop Stock a Buy or Sell After a Director Sold 2,700 Shares?
On Feb. 25, 2026, Wingstop (NASDAQ:WING) Director Kilandigalu Madati reported an open-market sale of 2,700 shares, valued at approximately $704,000, according to the SEC Form 4 filing.
Transaction
An Investor Just Bought $6 Million of This Stock That's Up 272% in a Year. Here's Whether It Still Has Room to Run
On February 17, 2026, Soviero Asset Management disclosed a new position in Vistance Networks (NASDAQ:VISN), acquiring 320,000 shares worth $5.80 million.
According to a filing with the Securities
Stock Market Today, March 10: Nvidia Gains on Optimism Around Expanding Enterprise AI Software Platform
Nvidia (NASDAQ:NVDA), a developer of GPUs and AI solutions for gaming, data centers, and autonomous vehicles, closed at $184.77, up 1.16%. The stock advanced as investors focused on optimism around
Down 22%, Is It Time to Buy CrowdStrike Stock on the Dip?
CrowdStrike (NASDAQ: CRWD) developed the Falcon cybersecurity platform, which is one of the industry's only holistic, all-in-one solutions. It protects the entire enterprise, from cloud networks to
This Fund Initiated a $5 Million Stake in Compass Amid Record Fourth Quarter
On February 17, 2026, Soviero Asset Management disclosed a new position in Compass (NYSE:COMP), acquiring 490,000 shares in a trade estimated at $5.18 million. The company delivers cloud-based
AMD CEO Lisa Su Believes Its Deal With Meta Platforms Will Be a Triple-Digit Billion Dollar Deal
In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special
Stock Market Today, March 10: American Airlines Falls After Analysts Cut Price Targets on Sector Pressures
American Airlines Group (NASDAQ:AAL), a major passenger and cargo carrier, closed Tuesday at $11.11, down 2.88%. The stock fell after analysts cut their price targets, while investors are watching
Why Stagwell Stock Surged Today
Shares of Stagwell (NASDAQ: STGW) popped on Tuesday after the artificial intelligence (AI)-powered marketing specialist issued an upbeat growth forecast.
By the close of trading, Stagwell's stock
Herc Stock Is Down 5% as One Fund Makes $6 Million Bet. Is Now the Time to Buy?
Soviero Asset Management disclosed a new position in Herc Holdings (NYSE:HRI) in its February 17, 2026, SEC filing, acquiring 38,000 shares in a trade estimated at $5.64 million based on quarter-end
Stock Market Today, March 10: Nio Surges After Posting First Quarterly Net Profit
Nio (NYSE:NIO), China-based designer and seller of electric vehicles, closed Tuesday at $5.7, up 15.38%. The stock moved higher after earnings showed Nio’s first-ever quarterly net profit and a
The Smartest Growth Stock to Buy With $1,000 Right Now
The artificial intelligence (AI) infrastructure market remains red-hot and a prime place to find attractive growth stocks. If you have $1,000, I think one of the best investments in the AI space
Fastly Stock Has Already Doubled This Year. Can It Keep Climbing?
Shares of Fastly (NASDAQ: FSLY) have been on an absolute tear. The stock has surged 112% already in 2026, easily crushing the S&P 500's decline of about 0.5% over the same period.
This massive rally
EQS-Adhoc: Gerresheimer AG: Publication of the 2025 annual and consolidated financial statements only after March 31, 2026, exclusion from the SDAX, postponement of the Annual General Meeting
Asset Manager Exits Shares of Hims & Hers Health
On February 17, 2026, BLKBRD Asset Management, LP, disclosed it sold out its entire stake in Hims & Hers Health (NYSE:HIMS), an estimated $18.07 million trade based on quarterly average pricing.
Marvell Technology Shares Jump on Strong AI Growth. Is It Too Late to Buy the Stock?
Share prices of Marvell Technology (NASDAQ: MRVL) surged last week after the company reported strong fiscal fourth-quarter results and issued upbeat guidance. The stock has been very up and down
According to SEC Filing, Thomas W. Smith Trimmed Yelp Stake as Local Services Advertising Reshapes the Business
According to an SEC filing dated February 17, 2026, SMITH THOMAS W reduced its position in Yelp (NYSE:YELP) by 96,280 shares during the fourth quarter. At quarter-end, the value of the position
The Best 3 Industrial Stocks to Buy in March
Industrial companies build the backbone of modern energy infrastructure, energy resilience, engineering and construction, and aerospace and defense technologies. These companies are crucial to the
Billionaire Steve Cohen Owns Shares of This Stock That Has Soared 1,600% in The Past Year
Investing in clinical-stage biotechs generally offers significant upside potential, along with a healthy, above-average dose of risk. Picking the right ones to put your hard-earned money into while



